Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Northwest Biotherapeutics Inc (NWBO)’

Doctor Specialties with Best Lifestyle

13G Filing: Sabby Capital and Northwest Biotherapeutics Inc (NWBO)

Northwest Biotherapeutics Inc (NASDAQ:NWBO): Hal Mintz’s Sabby Capital filed an amended 13D. You can check out Sabby Capital’s latest holdings......(read more)
Countries With Highest Medical Research Spending

13G Filing: Woodford Investment Management and Northwest Biotherapeutics Inc (NWBO)

Northwest Biotherapeutics Inc (NASDAQ:NWBO): Neil Woodford’s Woodford Investment Management filed an amended 13D. You can check out Woodford Investment......(read more)

13G Filing: Sabby Capital and Northwest Biotherapeutics Inc (NWBO)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Coach Inc. (COH), NYSE:COH, Yahoo Finance,

Here’s Why Traders Are Watching Coach, Red Robin, MGP Ingredients, and Two Other Stocks

Although the major indexes are relatively unchanged as the earnings results from Microsoft and other have failed to stir excitement in the broader market......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Why Are These Steel And Biotech Stocks Deep In Red Today?

There is strong market activity in the last full trading day ahead of the Christmas weekend. U.S. stocks are in green territory, with the Dow up by triple......(read more)

Woodford Investment Management Has A Lot Riding On These 5 Stocks

Woodford Investment Management recently filed its Form 13F with the U.S. Securities and Exchange Commission (SEC) for the reporting period of September......(read more)

Four Hot Biotechs Among The Day’s Big Winners

On a day when Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is deep in the red following the release of its third quarter earnings, four other biotech stocks......(read more)

Hedge Fund News: Louis Bacon, Paul Singer & Sandler Capital Management

Louis Bacon’s Moore Capital still sizzles despite Wizard exit (Standard) Louis Bacon’s $15 billion (£9.3 billion) hedge fund Moore Capital boosted......(read more)